RetractionCancer Chemother Pharmacol2022
Retraction Note to: Linc‑ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR‑124/PTBP1/PKM2 axis.
- Journal
- Cancer Chemother Pharmacol
- Published
- 1 January 2022
- Citations
- 0
- Type
- Retraction
- Retracted
- Yes
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try